Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucilla Parnetti

Showing results (91-100 of 283) with videos related to

Pageof 29
Sort By:
European Journal of Neurology|April 14, 2021
Novel noninvasive biomarkers of prodromal Alzheimer disease: The role of optical coherence tomography and optical coherence tomography-angiographyLeonardo Biscetti, Marco Lupidi, Elisa Luchetti, et al.
Trends in Pharmacological Sciences|October 31, 2020
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for TreatmentLorenzo Gaetani, Federico Paolini Paoletti, Giovanni Bellomo, et al.
Cerebrovascular Diseases (Basel, Switzerland)|March 15, 2006
Influence of dementia on antithrombotic therapy prescribed before stroke in patients with atrial fibrillationCatherine Lefebvre, Dominique Deplanque, Hilde Hénon, et al.
Journal of Alzheimer'S Disease : JAD|July 5, 2022
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical ValidationAnna Lidia Wojdała, Davide Chiasserini, Giovanni Bellomo, et al.
BMJ Open|June 15, 2016
Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysisPaolo Eusebi, David Giannandrea, Leonardo Biscetti, et al.
BMJ Open|November 25, 2017
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysisPaolo Eusebi, Oskar Hansson, Silvia Paciotti, et al.
Epilepsy Research|October 3, 2008
Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational studyVincenzo Belcastro, Cinzia Costa, Francesca Galletti, et al.
Journal of Neurology|November 25, 2021
The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRIElena Di Sabatino, Lorenzo Gaetani, Silvia Sperandei, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|July 31, 2022
Repeatable Battery for the Assessment of Neuropsychological Status: Italian Normative Data for Older AdultsElena Chipi, Daniela Fruttini, Nicola Salvadori, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2022
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as BiomarkersLorenzo Barba, Federico Paolini Paoletti, Giovanni Bellomo, et al.
Pageof 29

Showing results (91-100 of 283) with videos related to

Sort By:
Pageof 29
European Journal of Neurology|April 14, 2021
Novel noninvasive biomarkers of prodromal Alzheimer disease: The role of optical coherence tomography and optical coherence tomography-angiographyLeonardo Biscetti, Marco Lupidi, Elisa Luchetti, et al.
Trends in Pharmacological Sciences|October 31, 2020
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for TreatmentLorenzo Gaetani, Federico Paolini Paoletti, Giovanni Bellomo, et al.
Cerebrovascular Diseases (Basel, Switzerland)|March 15, 2006
Influence of dementia on antithrombotic therapy prescribed before stroke in patients with atrial fibrillationCatherine Lefebvre, Dominique Deplanque, Hilde Hénon, et al.
Journal of Alzheimer'S Disease : JAD|July 5, 2022
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical ValidationAnna Lidia Wojdała, Davide Chiasserini, Giovanni Bellomo, et al.
BMJ Open|June 15, 2016
Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysisPaolo Eusebi, David Giannandrea, Leonardo Biscetti, et al.
BMJ Open|November 25, 2017
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysisPaolo Eusebi, Oskar Hansson, Silvia Paciotti, et al.
Epilepsy Research|October 3, 2008
Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational studyVincenzo Belcastro, Cinzia Costa, Francesca Galletti, et al.
Journal of Neurology|November 25, 2021
The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRIElena Di Sabatino, Lorenzo Gaetani, Silvia Sperandei, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|July 31, 2022
Repeatable Battery for the Assessment of Neuropsychological Status: Italian Normative Data for Older AdultsElena Chipi, Daniela Fruttini, Nicola Salvadori, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2022
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as BiomarkersLorenzo Barba, Federico Paolini Paoletti, Giovanni Bellomo, et al.
Pageof 29